KDventures AB【0P3C】銘柄情報

KDventures AB (0P3C) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

6.50

( - )

買値

6.50

売値

6.50

出来高

0.00

0.00 日の範囲 0.00

6.50 52 週間の範囲 6.50

時価総額

4.285B

前日終値

6.50

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

SEK 1,519,610

発行済株式数

659,283,843

配当利回り

PER

-0.41

1 株当たり利益 (EPS)

-0.66

歳入

1.56M

純利益

-213.8M

KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery tech... KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. The company was formerly known as Karolinska Development AB (publ) and change its name to KDventures AB in February 2026. KDventures AB was founded in 2003 and is headquartered in Solna, Sweden. 詳細を表示

セクター

業界

ウェブサイト

www.karolinskadevelopment.com

本社

Solna, Sweden

設立

2026

KDventures AB is listed in the sector of the ロンドン証券取引所 with ticker 0P3C. The last closing price for KDventures AB was SEK6.50. Over the last year, KDventures AB shares have traded in a share price range of SEK 6.50 to SEK 6.50.

KDventures AB currently has 659,283,843 shares in issue. The market capitalisation of KDventures AB is SEK4.29 billion. KDventures AB has a price to earnings ratio (PE ratio) of -0.41.

KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS

KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS STOCKHOLM...

Change of number of shares and votes in KDventures AB

Change of number of shares and votes in KDventures AB STOCKHOLM, SWEDEN – February 27, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces...

KDventures’s portfolio company SVF Vaccines announces that the intended merger with Novakand will not be carried out following negative decision from Nasdaq

KDventures’s portfolio company SVF Vaccines announces that the intended merger with Novakand will not be carried out following negative decision...

Year-end Report - January-December 2025

Year-end Report - January-December 2025 STOCKHOLM – 13 February 2025. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Year-end Report...

KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue

KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue NOT FOR RELEASE...

KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer

KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer STOCKHOLM, Sweden, 10 February 2026. KDventures AB...

Karolinska Development’s portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement

Karolinska Development’s portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement STOCKHOLM, Sweden...

Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB

Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB NOT FOR RELEASE...

Karolinska Development AB receives additional guarantee commitments in ongoing rights issue

Karolinska Development AB receives additional guarantee commitments in ongoing rights issue NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY...

Karolinska Development’s portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin

Karolinska Development’s portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin STOCKHOLM...

期間 †	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	6.5	6.5	6.5	344	6.5	DE
52	6.5	6.5	6.5	2128	6.5	DE
156	6.5	6.5	6.5	781	6.5	DE
260	6.5	6.5	6.5	876	6.5	DE

0P3C - Frequently Asked Questions (FAQ)

What is the current KDventures AB share price?

The current share price of KDventures AB is SEK 6.50

How many KDventures AB shares are in issue?

KDventures AB has 659,283,843 shares in issue

What is the market cap of KDventures AB?

The market capitalisation of KDventures AB is SEK 4.29B

What is the 1 year trading range for KDventures AB share price?

KDventures AB has traded in the range of SEK 6.50 to SEK 6.50 during the past year

What is the PE ratio of KDventures AB?

The price to earnings ratio of KDventures AB is -0.41

What is the cash to sales ratio of KDventures AB?

The cash to sales ratio of KDventures AB is 114.94

What is the registered address of KDventures AB?

The registered address for KDventures AB is Nanna Svartz väg 6A, Solna, Stockholm County, 17165

What is the KDventures AB website address?

The website address for KDventures AB is www.karolinskadevelopment.com

Monksdream 4分前

Global Mofy AI Ltd. is a holding company, which engages in AI-Driven technology solutions provider engaged in virtual content production, and digital assets development for the digital content industry. The firm utilizes its “Mofy Lab” technology platform, which consists of 3D rebuilt technology AI

GMM

Hi_Lo 4分前

Hawkins involved here.

This is NOT a Richard Hawkins company. He is only a consultant. There is a BIG difference. He doesn't run the company nor is he personally invested. He can also be easily over-ruled as a conultant. He can't run this company as he sees fit.

And I c

CBGL

Monksdream 5分前

GMM, there it goes

GMM

QaB2i 7分前

“ ….. ( you) would say they are Developed a bit beyond that characterization”
Is that your personal opinion or is that based on non public information?

EDGM

US Market News 9分前

Invitation Homes Announces Cash DividendJune 12, 2026 6:45 AM
Business Wire Invitation Homes Inc. (NYSE: INVH) (“Invitation Homes,” the “Company,” or “our”), the nation’s premier single-family home leasing and management company, announced today that it has declared a quarterly

INVH

US Market News 9分前

Booz Allen Hamilton to Host Conference Call to Discuss First Quarter Fiscal 2027 Results on Friday, July 24, 2026June 12, 2026 6:45 AM
Business Wire Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of advanced technology company Booz Allen Hamilton Inc.,

BAH

US Market News 9分前

Build-A-Bear Workshop Completes Planned CEO SuccessionJune 12, 2026 6:45 AM
Business Wire Announces Leadership Updates to Support Continued Business Evolution Build-A-Bear Workshop, Inc. (NYSE: BBW) today announced that Chris Hurt has assumed the role

BBW

US Market News 9分前

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 MillionJune 12, 2026 7:00 AM
Business Wire

RCKT

ScottishTexan 10分前

The only reason it’s this high is the sandbox speculation. If it doesn’t happen and ends up being another otc dilution scam that comes in it’ll drop like a stone. The recent purchase of a $100k note for $1k and hiring a guy who graduated last year as a board advisor are not indicative of a multi bil

VGLS

Investor082 12分前

At this point given how long this has gone on despite political support, they are likely debating accepting a very restrictive label with no NICE support for a couple of years at the very least or staying in this limbo for the foreseeable future or accepting rejection.

The new Roswell

NWBO

Monksdream 15分前

TOP 15
https://www.advfn.com/markets/nasdaq/premarket

HGiLS 15分前

It depends who you ask on this board lol.

The only constant valuation is bridge builder’s.

😂

ELTP

Investor082 17分前

By the way, Dr. Analisa Jenkins is not the real deal. Look at all the companies she is involved in on her LinkedIn profile currently. All of them appear well under $100M market cap and many struggling for multiple years. Skye Bioscience, Cocoon, Phaim Pharma, etc.

It appears that NWB

NWBO

BornAgain 18分前

Looks like the BWMG team is keeping itself busy!!

BWMG

indepth05 19分前

A scoreboard isn’t very impressive when you’re the player, referee, statistician, and sole fan in the stadium. 🤡You call it a scoreboard. Everyone else here calls it self-scoring. 🤡

LEHNQ

BornAgain 20分前

https://www.otcmarkets.com/stock/BWMG/news/Brownies-Marine-Group-and-Mountains-to-Seas-to-Showcase-Awake-Electric-Surfboards-at-Atlanta-Foil-Fest?id=524719

BWMG

TheRealSarsoor 21分前

Good Morning $HGRAF

HGRAF

US Market News 24分前

Vertiv Completes Acquisition of ThermoKey, Expanding Heat Rejection Portfolio for AI Data CentersJune 12, 2026 6:30 AM
PR Newswire (US) Acquisition expected to strengthen thermal management capabilities and manufacturing capacity in Europ

VRT

iHub News 24分前

Adobe Beats Expectations and Raises Outlook, but Shares Fall on ARR Concerns (ADBE)June 12, 2026 6:25 AM
IH Market News

ADBE

nowwhat2 29分前

It depend on dis ;

https://investorshub.advfn.com/uimage/uploads/2026/6/12/kqvogbtc_june_11_6m_SUMMARY_DIE_CUP_200_PLAIN.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/oiltidepend_maj.jpg

https://invest

BTCUSD

jimmybob 33分前

$SMCI PT lowered to $39 From $45 at Raymond James - keeps Outperform rated

May 6th $35->$45
Feb 6th $50->$35

SMCI

Investor082 33分前

Gary, you seem to be a naive investor. No wonder your perspective of a good pre revenue biotech stock is survival for multiple decades (close to 40 years, LOL).

The market cap of many stocks go down as years go by despite hitting more milestones because investors lose confidence in t

NWBO

ExtremelyBullishZig 34分前

Should have listened to my extreme bull sh t...huh?
I have been saying that way longer than you...

AVXL

NASDAQ2020 34分前

How much did THE buyout price just go up ?????🚀

E”TP

ELTP

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

KDventures AB (0P3C)